Episode 31
In this podcast we’re joined by Tim Hunt, CEO of Alliance for Regenerative Medicine (ARM).
As an international advocacy organization, ARM is a global voice within the cell and gene therapy sector.
It champions the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society as well as facilitating influential exchanges on policies and practices, and advances in narrative with data and analysis.
In this episode, Tim and Jason C. Foster discuss why it is important to put the patient first and where we should be focusing our attention to reduce the cost of goods and improve the accessibility of cell and gene therapies. Tim also offers his advice for people and companies working in the CGT space.
Further information